Related Experiment Videos
Posttranscription regulation of prostate cancer growth
1Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21231, USA.
Abstract:
Advances in the understanding of the molecular mechanisms implicated in prostate cancer progression have allowed identification of many potential therapeutic gene targets that are involved in apoptosis, growth factors, cell signaling, and the androgen receptor. A critical factor responsible for the malignant progression of prostate cancer is the abnormal expression and function of specific proteins. From the transcription of mRNA to the translation of proteins and their function, several steps can be exploited as "drugable" targets. In this article we will review some of the key molecular targets and posttranscriptional strategies that are currently being tested both preclinically and clinically as targeted therapeutic approach for prostate cancer. Most of the targets mentioned in this review involve the prostate cancer signal transduction cascade, and their functions include prosurvival, antiapoptosis, and proangiogenesis. We will focus in particular on the emerging role of the "chromatin modifiers," histone deacetylase inhibitors, not only in transcriptional gene regulation but also in posttranscriptional protein modifications as a tool for therapeutic intervention in prostate cancer.
Insights
Targeted therapies for prostate cancer are advancing by focusing on molecular mechanisms like apoptosis and cell signaling. This review highlights key drug targets and chromatin modifiers, such as histone deacetylase inhibitors, for therapeutic intervention.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Prostate cancer progression is linked to abnormal protein expression and function.
- Understanding molecular mechanisms offers potential therapeutic gene targets.
Purpose of the Study:
- To review key molecular targets and posttranscriptional strategies for prostate cancer therapy.
- To highlight the role of chromatin modifiers, like histone deacetylase inhibitors, in therapeutic intervention.
Main Methods:
- Review of preclinical and clinical studies on targeted therapeutic approaches for prostate cancer.
- Focus on signal transduction pathways, including apoptosis, growth factors, and androgen receptor signaling.
- Examination of transcriptional and posttranscriptional gene regulation strategies.
Main Results:
- Identification of multiple "drugable" targets from mRNA transcription to protein function.
- Prostate cancer signal transduction cascade targets often promote survival, inhibit apoptosis, and drive angiogenesis.
- Emerging role of histone deacetylase inhibitors in gene regulation and protein modification.
Conclusions:
- Targeted therapies offer promising avenues for prostate cancer treatment.
- Exploiting molecular targets and posttranscriptional modifications can overcome cancer progression.
- Histone deacetylase inhibitors represent a significant area for therapeutic development in prostate cancer.
Related Concept Videos
Regulation of Expression at Multiple Steps
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Negative Regulator Molecules